المؤلفون: Yuen M.-F., Agarwal K., Gane E.J., Schwabe C., Ahn S.H., Kim D.J., Lim Y.-S., Cheng W., Sievert W., Visvanathan K., Ruby E., Liaw S., Yan R., Huang Q., Colonno R., Lopatin U.

مصطلحات الفهرس: drug dose reduction, drug efficacy, drug elimination, drug half life, drug safety, drug tolerability, drug withdrawal, dry throat/si [Side Effect], eczema/si [Side Effect], epistaxis/si [Side Effect], faintness/si [Side Effect], fasting, fatigue/si [Side Effect], female, flu like syndrome/si [Side Effect], gastroenteritis/si [Side Effect], gastroesophageal reflux/si [Side Effect], gingiva pain/si [Side Effect], headache/si [Side Effect], heart palpitation/si [Side Effect], hematoma/si [Side Effect], hepatitis B/dt [Drug Therapy], hepatitis B/si [Side Effect], human, hypertension/si [Side Effect], increased appetite/si [Side Effect], injection site reaction/si [Side Effect], insomnia/si [Side Effect], maculopapular rash/si [Side Effect], male, maximum plasma concentration, mental instability/si [Side Effect], mouth ulcer/si [Side Effect], multiple drug dose, musculoskeletal pain/si [Side Effect], mycosis/si [Side Effect], nausea/si [Side Effect], neck pain/si [Side Effect], nose obstruction/si [Side Effect], oropharynx pain/si [Side Effect], pain/si [Side Effect], petechia/si [Side Effect], pharmacokinetics, phase 1 clinical trial, photosensitivity/si [Side Effect], pigmented nevus/si [Side Effect], positional dizziness/si [Side Effect], priority journal, pruritus/si [Side Effect], randomized controlled trial, rash/si [Side Effect], real time polymerase chain reaction, rhinorrhea/si [Side Effect], single drug dose, skin bruising/si [Side Effect], skin irritation/si [Side Effect], skin manifestation/si [Side Effect], sprain/si [Side Effect], sunburn/si [Side Effect], sweat gland disease/si [Side Effect], thorax pain/si [Side Effect], time to maximum plasma concentration, tonsillitis/si [Side Effect], treatment response, upper abdominal pain/si [Side Effect], virus load, volume of distribution, vomiting/si [Side Effect], wound/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], hepatitis B core antibody/ae [Adverse Drug Reaction], hepatitis B core antibody/ct [Clinical Trial], hepatitis B core antibody/cm [Drug Comparison], hepatitis B core antibody/cr [Drug Concentration], hepatitis B core antibody/do [Drug Dose], hepatitis B core antibody/dt [Drug Therapy], hepatitis B core antibody/po [Oral Drug Administration], hepatitis B core antibody/pk [Pharmacokinetics], hepatitis B core antigen, hepatitis B surface antigen, hepatitis B(e) antigen, placebo, virus DNA, virus RNA, dysgeusia/si [Side Effect], presyncope/si [Side Effect], abdominal discomfort/si [Side Effect], abdominal distension/si [Side Effect], abdominal pain/si [Side Effect], adult, allergy/si [Side Effect], antiviral activity, area under the curve, article, asthenopia/si [Side Effect], backache/si [Side Effect], catheter infection/si [Side Effect], chronic hepatitis B/dt [Drug Therapy], chronic hepatitis B/si [Side Effect], clinical article, cohort analysis, conjunctivitis/si [Side Effect], constipation/si [Side Effect], controlled study, coughing/si [Side Effect], crackle/si [Side Effect], decreased appetite/si [Side Effect], dehydration/si [Side Effect], diarrhea/si [Side Effect], dizziness/si [Side Effect], drug dose comparison, drug dose increase, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29395
Click here for full text options
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Yuen M.-F., Agarwal K., Gane E.J., Schwabe C., Ahn S.H., Kim D.J., Lim Y.-S., Cheng W., Sievert W., Visvanathan K., Ruby E., Liaw S., Yan R., Huang Q., Colonno R., Lopatin U.

مصطلحات الفهرس: drug dose reduction, drug efficacy, drug elimination, drug half life, drug safety, drug tolerability, drug withdrawal, dry throat/si [Side Effect], eczema/si [Side Effect], epistaxis/si [Side Effect], faintness/si [Side Effect], fasting, fatigue/si [Side Effect], female, flu like syndrome/si [Side Effect], gastroenteritis/si [Side Effect], gastroesophageal reflux/si [Side Effect], gingiva pain/si [Side Effect], headache/si [Side Effect], heart palpitation/si [Side Effect], hematoma/si [Side Effect], hepatitis B/dt [Drug Therapy], hepatitis B/si [Side Effect], human, hypertension/si [Side Effect], increased appetite/si [Side Effect], injection site reaction/si [Side Effect], insomnia/si [Side Effect], maculopapular rash/si [Side Effect], male, maximum plasma concentration, mental instability/si [Side Effect], mouth ulcer/si [Side Effect], multiple drug dose, musculoskeletal pain/si [Side Effect], mycosis/si [Side Effect], nausea/si [Side Effect], neck pain/si [Side Effect], nose obstruction/si [Side Effect], oropharynx pain/si [Side Effect], pain/si [Side Effect], petechia/si [Side Effect], pharmacokinetics, phase 1 clinical trial, photosensitivity/si [Side Effect], pigmented nevus/si [Side Effect], positional dizziness/si [Side Effect], priority journal, pruritus/si [Side Effect], randomized controlled trial, rash/si [Side Effect], real time polymerase chain reaction, rhinorrhea/si [Side Effect], single drug dose, skin bruising/si [Side Effect], skin irritation/si [Side Effect], skin manifestation/si [Side Effect], sprain/si [Side Effect], sunburn/si [Side Effect], sweat gland disease/si [Side Effect], thorax pain/si [Side Effect], time to maximum plasma concentration, tonsillitis/si [Side Effect], treatment response, upper abdominal pain/si [Side Effect], virus load, volume of distribution, vomiting/si [Side Effect], wound/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], hepatitis B core antibody/ae [Adverse Drug Reaction], hepatitis B core antibody/ct [Clinical Trial], hepatitis B core antibody/cm [Drug Comparison], hepatitis B core antibody/cr [Drug Concentration], hepatitis B core antibody/do [Drug Dose], hepatitis B core antibody/dt [Drug Therapy], hepatitis B core antibody/po [Oral Drug Administration], hepatitis B core antibody/pk [Pharmacokinetics], hepatitis B core antigen, hepatitis B surface antigen, hepatitis B(e) antigen, placebo, virus DNA, virus RNA, dysgeusia/si [Side Effect], presyncope/si [Side Effect], abdominal discomfort/si [Side Effect], abdominal distension/si [Side Effect], abdominal pain/si [Side Effect], adult, allergy/si [Side Effect], antiviral activity, area under the curve, article, asthenopia/si [Side Effect], backache/si [Side Effect], catheter infection/si [Side Effect], chronic hepatitis B/dt [Drug Therapy], chronic hepatitis B/si [Side Effect], clinical article, cohort analysis, conjunctivitis/si [Side Effect], constipation/si [Side Effect], controlled study, coughing/si [Side Effect], crackle/si [Side Effect], decreased appetite/si [Side Effect], dehydration/si [Side Effect], diarrhea/si [Side Effect], dizziness/si [Side Effect], drug dose comparison, drug dose increase, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29395
The Lancet Gastroenterology and Hepatology
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Fida R., Wilks A., Burge M., Francesconi A.B., Kotasek D., Smith G., Lickliter J.D., Vasey P.A.

مصطلحات الفهرس: drug dose increase, drug half life, drug induced headache/si [Side Effect], drug intermittent therapy, drug safety, drug tolerability, fatigue/si [Side Effect], female, human, hypertension/si [Side Effect], hypoxia/si [Side Effect], infection/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung small cell cancer/dt [Drug Therapy], male, maximum plasma concentration, multicenter study, multiple cycle treatment, abdominal distension/si [Side Effect], adrenal cortex carcinoma/dt [Drug Therapy], adult, advanced cancer, aged, anemia/si [Side Effect], anorexia/si [Side Effect], area under the curve, article, ascites/si [Side Effect], breast cancer/dt [Drug Therapy], chemotherapy induced emesis/si [Side Effect], clinical article, colorectal cancer/dt [Drug Therapy], constipation/si [Side Effect], contrast enhancement, dehydration/si [Side Effect], drug bioavailability, drug dose escalation, nausea/si [Side Effect], nuclear magnetic resonance imaging, pancreas adenocarcinoma/dt [Drug Therapy], pharmacodynamics, phase 1 clinical trial, portal vein thrombosis/si [Side Effect], priority journal, protein blood level, QT prolongation/si [Side Effect], side effect/si [Side Effect], sinus tachycardia/si [Side Effect], solid tumor/dt [Drug Therapy], sweating, thymoma/dt [Drug Therapy], time to maximum plasma concentration, gadolinium pentetate meglumine/iv [Intravenous Drug Administration], lexibulin/ae [Adverse Drug Reaction], lexibulin/ct [Clinical Trial], lexibulin/cr [Drug Concentration], lexibulin/dt [Drug Therapy], lexibulin/po [Oral Drug Administration], lexibulin/pk [Pharmacokinetics], vascular targeting agent/ae [Adverse Drug Reaction], vascular targeting agent/ct [Clinical Trial], vascular targeting agent/cr [Drug Concentration], vascular targeting agent/dt [Drug Therapy], vascular targeting agent/po [Oral Drug Administration], vascular targeting agent/pk [Pharmacokinetics], von Willebrand factor/ec [Endogenous Compound], Article

URL: Click here for full text options
LibKey Link

المؤلفون: Fida R., Wilks A., Burge M., Francesconi A.B., Kotasek D., Smith G., Lickliter J.D., Vasey P.A.

مصطلحات الفهرس: drug dose increase, drug half life, drug induced headache/si [Side Effect], drug intermittent therapy, drug safety, drug tolerability, fatigue/si [Side Effect], female, human, hypertension/si [Side Effect], hypoxia/si [Side Effect], infection/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung small cell cancer/dt [Drug Therapy], male, maximum plasma concentration, multicenter study, multiple cycle treatment, abdominal distension/si [Side Effect], adrenal cortex carcinoma/dt [Drug Therapy], adult, advanced cancer, aged, anemia/si [Side Effect], anorexia/si [Side Effect], area under the curve, article, ascites/si [Side Effect], breast cancer/dt [Drug Therapy], chemotherapy induced emesis/si [Side Effect], clinical article, colorectal cancer/dt [Drug Therapy], constipation/si [Side Effect], contrast enhancement, dehydration/si [Side Effect], drug bioavailability, drug dose escalation, nausea/si [Side Effect], nuclear magnetic resonance imaging, pancreas adenocarcinoma/dt [Drug Therapy], pharmacodynamics, phase 1 clinical trial, portal vein thrombosis/si [Side Effect], priority journal, protein blood level, QT prolongation/si [Side Effect], side effect/si [Side Effect], sinus tachycardia/si [Side Effect], solid tumor/dt [Drug Therapy], sweating, thymoma/dt [Drug Therapy], time to maximum plasma concentration, gadolinium pentetate meglumine/iv [Intravenous Drug Administration], lexibulin/ae [Adverse Drug Reaction], lexibulin/ct [Clinical Trial], lexibulin/cr [Drug Concentration], lexibulin/dt [Drug Therapy], lexibulin/po [Oral Drug Administration], lexibulin/pk [Pharmacokinetics], vascular targeting agent/ae [Adverse Drug Reaction], vascular targeting agent/ct [Clinical Trial], vascular targeting agent/cr [Drug Concentration], vascular targeting agent/dt [Drug Therapy], vascular targeting agent/po [Oral Drug Administration], vascular targeting agent/pk [Pharmacokinetics], von Willebrand factor/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/42634
LibKey Link

المؤلفون: Muir J.G., Lu Z.X., Walker K.Z., O'Dea K.

مصطلحات الفهرس: crossover procedure, diabetes control, diarrhea/si [Side Effect], diet restriction, diet supplementation, dietary fiber, dietary intake, feces analysis, female, flatulence/si [Side Effect], flour, fructosamine blood level, glucose blood level, health care facility, human, insulin blood level, lipid blood level, male, medical documentation, metabolic regulation, non insulin dependent diabetes mellitus/dt [Drug Therapy], patient compliance, randomized controlled trial, statistical analysis, venous blood, wheat, antihypertensive agent/dt [Drug Therapy], antilipemic agent/dt [Drug Therapy], arabinoxylan/ae [Adverse Drug Reaction], arabinoxylan/ct [Clinical Trial], arabinoxylan/dt [Drug Therapy], arabinoxylan/pd [Pharmacology], fructosamine/ec [Endogenous Compound], glucose/ec [Endogenous Compound], insulin/ec [Endogenous Compound], lipid/ec [Endogenous Compound], oral antidiabetic agent/dt [Drug Therapy], oral antidiabetic agent/po [Oral Drug Administration], polysaccharide, abdominal distension/si [Side Effect], adult, article, Australia, blood pressure measurement, blood sampling, body fat, body mass, body weight, bread, clinical article, clinical trial, confidence interval, controlled clinical trial, controlled study, abdominal cramp/si [Side Effect], abdominal disease/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32515
Click here for full text options
LibKey Link

المؤلفون: Muir J.G., Lu Z.X., Walker K.Z., O'Dea K.

مصطلحات الفهرس: crossover procedure, diabetes control, diarrhea/si [Side Effect], diet restriction, diet supplementation, dietary fiber, dietary intake, feces analysis, female, flatulence/si [Side Effect], flour, fructosamine blood level, glucose blood level, health care facility, human, insulin blood level, lipid blood level, male, medical documentation, metabolic regulation, non insulin dependent diabetes mellitus/dt [Drug Therapy], patient compliance, randomized controlled trial, statistical analysis, venous blood, wheat, antihypertensive agent/dt [Drug Therapy], antilipemic agent/dt [Drug Therapy], arabinoxylan/ae [Adverse Drug Reaction], arabinoxylan/ct [Clinical Trial], arabinoxylan/dt [Drug Therapy], arabinoxylan/pd [Pharmacology], fructosamine/ec [Endogenous Compound], glucose/ec [Endogenous Compound], insulin/ec [Endogenous Compound], lipid/ec [Endogenous Compound], oral antidiabetic agent/dt [Drug Therapy], oral antidiabetic agent/po [Oral Drug Administration], polysaccharide, abdominal distension/si [Side Effect], adult, article, Australia, blood pressure measurement, blood sampling, body fat, body mass, body weight, bread, clinical article, clinical trial, confidence interval, controlled clinical trial, controlled study, abdominal cramp/si [Side Effect], abdominal disease/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32515
LibKey Link